Which SGA has an FDA approval for use in those aged 12 and older?

Prepare for the Advanced Pharmacology – Psychopharmacology exam. Study with interactive quizzes, flashcards, and detailed explanations for each question. Enhance your understanding and ace your test!

Paliperidone is a second-generation antipsychotic (SGA) that has received FDA approval for use in individuals aged 12 and older, specifically for the treatment of schizophrenia and schizoaffective disorder in adolescents. This approval allows healthcare providers to prescribe paliperidone for this age group, addressing various psychiatric conditions with an evidence-based approach.

The other options may have specific age limits or indications that do not include the adolescent population. For instance, while asenapine, clozapine, and quetiapine are utilized in various psychiatric disorders, their FDA indications differ when it comes to age-related approvals, with some being indicated primarily for adults or having restrictions in pediatric populations. Hence, paliperidone stands out for its specific FDA approval covering the 12-and-older demographic, making it the appropriate choice in this context.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy